John Robinson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Robinson
John Robinson is recorded as CEO at PROG Holdings, Inc. (PRG). The proxy statement of Cogent Biosciences, Inc. reports total compensation of $9,150,297 for John Robinson in fiscal 2025, including a base salary of $532,035. Disclosed compensation is on record for 5 fiscal years. John Robinson has spoken on 2 earnings calls across 1 company, most recently for PROG Holdings, Inc. on October 29, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Cogent Biosciences, Inc. (COGT)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at PROG Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven A. Michaels CEO, Chairman, Board Member
- John W. Robinson III Chairman
- Steve Michaels Chairman
- Brian Garner CFO
- C. Kelly Wall CFO
- Ben Hawksworth CIO
- Todd King General Counsel
- Caroline S. Sheu Board Member
- Caroline Sheu Board Member
- Curtis L. Doman Board Member
Leadership on record at Cogent Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Robbins CEO, Board Member
- Peter Harwin Chairman, Board Member
- John Green CFO
- John L. Green CFO
- Arlene M. Morris Board Member
- Chris Cain Board Member
- Chris Cain, Ph.D. Board Member
- Karen Ferrante Board Member
- Matthew E. Ros Board Member
- Todd E. Shegog Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cogent Biosciences, Inc. (COGT) | Chief Scientific Officer | $532,035 | $9,150,297 |
| 2024 | Cogent Biosciences, Inc. (COGT) | Chief Scientific Officer | $510,775 | $1,807,431 |
| 2023 | Cogent Biosciences, Inc. (COGT) | Chief Scientific Officer | $491,130 | $2,975,911 |
| 2022 | Cogent Biosciences, Inc. (COGT) | Chief Scientific Officer | $454,178 | $1,869,151 |
| 2021 | Cogent Biosciences, Inc. (COGT) | Chief Scientific Officer | $315,481 | $3,473,113 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.